Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
(PAR-22-073)
National Cancer Institute
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Institute for Occupational Safety and Health
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): December 15, 2021; February 2, 2022; November 15, 2022; February 2, 2023; November 15, 2023; February 2, 2024 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
(RFA-AT-22-003)
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Office of Research on Women’s Health
Application Receipt Date(s): February 11, 2022
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
(RFA-DA-22-036)
National Institute on Drug Abuse
National Institute on Aging
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): March 02, 2022
Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed)
(RFA-AG-23-004)
National Institute on Aging
Application Receipt Date(s): March 03, 2022
Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
(RFA-MH-22-150)
National Institute of Mental Health
Application Receipt Date(s): February 22, 2023
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
(RFA-HL-23-009)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 28, 2024
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
(RFA-HL-23-008)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
Application Receipt Date(s): February 28, 2024
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional)
(PAR-21-353)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 05, 2024
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 – Clinical Trial Optional)
(PAR-21-354)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 16, 2024
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 – Clinical Trial Optional)
(PAR-21-355)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 16, 2024
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
(PAR-22-072)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): Multiple dates, see announcement.